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Eukaryotic, bacterial, and archaeal cells contain a large
number of integral membrane proteins and protein complexes
involved in solute transport across the membrane (48). In
Escherichia coli as many as 10.8% of all chromosomal genes
code for membrane transport proteins (65). All known and
putative transport proteins have recently been classified in
different families based on their sequence similarities. This led
to the identification of 159 transporter families, of which sec-
ondary transporters represent the largest functional category,
comprising 59 families (73).
Secondary transporters use the free energy stored in ion
and/or solute gradients over the membrane to drive transport.
Since three-dimensional structures of secondary transporters
have not yet been solved, models for their structures are based
on biochemical data and on (computational) analysis of their
amino acid sequences. A typical secondary transporter consists
of a single polypeptide component that forms a bundle of
membrane-spanning a-helices connected by loops of various
sizes. Many of these proteins contain 12 membrane-spanning
segments, but different numbers are not exceptional (73). The
59 families of secondary transporters do not represent as many
different global structures. It has been shown by hydropathy
profile analysis that many of the families belong to the same
structural class (53, 54). One of the families that forms a
separate structural class is the glutamate transporter family,
also called dicarboxylate/cation symporters (DCS; transporter
classification 2.23) (73).
The glutamate transporter family includes transporters that
are found in neurons and glial cells in the mammalian central
nervous system and catalyze the reuptake of the excitatory
neurotransmitter glutamate from the synaptic cleft (26, 38, 67,
81). Excessive amounts of extracellular glutamate, associated
with several diseases, cause neuronal destruction via activation
of the N-methyl-D-aspartate receptors (57, 60). The neuronal
and glial glutamate transporters are believed to prevent exci-
totoxicity of glutamate (52, 71, 83) and may help to end the
excitatory signal together with diffusion (58, 63). Since these
proteins have been implicated in numerous neurological dis-
orders, they have attracted much attention and have been well
characterized.
The number of known transporters in the glutamate trans-
porter family has grown rapidly during the last years, and many
members of the family have now been characterized, including
retinal glutamate transporters from vertebrates (3, 22), mam-
malian neutral-amino-acid transporters (5, 51, 75), and bacte-
rial nutrient uptake proteins (23, 85, 86). Because of the variety
of transporters that are being studied in the glutamate trans-
porter family and the numerous techniques used to study them,
the structural features of the transporter family are now rap-
idly being unraveled. This review focuses on the diversity of
transporters in the family and on their structural properties.
Physiological and pathological aspects have recently been re-
viewed elsewhere (37, 94).
THE FAMILY
Substrate Specificity
The members of the glutamate transporter family that have
been functionally characterized can be classified in three
groups based on their substrate specificity (Table 1): C4-dicar-
boxylate transporters (found in bacteria), glutamate/aspartate
transporters (found in bacteria and eukaryotes) and neutral-
amino-acid transporters (found in bacteria and eukaryotes).
The bacterial C4-dicarboxylate carriers transport the tricarbox-
ylic acid cycle intermediates succinate, fumarate, and malate
(28, 29). In addition, the transporter from Rhizobium meliloti
uses aspartate (106) and the transporters from Escherichia coli
and Salmonella typhimurium use orotate as substrate (6). It is
not known which transmembrane ion or solute gradient(s)
provides the free energy to drive transport.
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All glutamate transporters use L-glutamate and L-aspartate
as high-affinity substrates (Km [Glu] , 100mM). In addition,
several (nonphysiological) glutamate analogues are trans-
ported (38, 67, 81, 85, 88, 104). The bacterial proteins catalyze
the electrogenic symport of glutamate with at least two cations
(85, 87, 88). The GltP proteins from E. coli and Bacillus subtilis
use protons to drive the uptake of glutamate, whereas the GltT
proteins from Bacillus stearothermophilus and Bacillus caldo-
tenax can replace one proton with a sodium ion (34). Na1 is
preferentially used at elevated temperatures, but the selectivity
for sodium ions is lost when these transporters are expressed in
E. coli (87). These observations indicate that minor conforma-
tional changes may alter the cation specificity.
The eukaryotic glutamate transporters catalyze the electro-
genic symport of glutamate with two or three sodium ions and
one proton, whereas one potassium ion is antiported (2, 7, 24,
43, 112). The exact number of transported sodium ions is still
a matter of debate (37, 39, 50, 112), but a stoichiometry of
three sodium ions per glutamate is generally favored (50, 112).
Transport of glutamate by the eukaryotic proteins is strictly
dependent on sodium ions, but not all Na1 binding sites are
equally selective. For the glutamate transporter EAAT2 of rats
(also known as GLT-1), it was shown that only one Na1 bind-
ing site strictly requires sodium ions whereas lithium ions can
replace Na1 in the others (33). Cesium, rubidium, and ammo-
nium ions can replace K1 to various extents (44).
The high-affinity substrates for the mammalian neutral-ami-
no-acid transporters are alanine, serine, cysteine, and threo-
nine (Km , 100 mM), but some members (ACST2 from mice,
humans, and rabbits) show a broader substrate specificity and
accept glutamine and asparagine with high affinity and several
other amino acids, including glutamate, with lower affinity (Km
. 300 mM) (5, 45, 46, 82, 93). The human neutral amino acid
transporter ASCT1 is an obligate exchanger that does not
mediate a net flux of amino acids (111). Exchange of the amino
acids is electroneutral and accompanied by a symmetrical ex-
change of one Na1. In contrast, mouse ASCT2 may exchange
Na1 for K1 during turnover (93). Recently, a serine trans-
porter from E. coli that is an Na1 symporter (61) was charac-
terized.
Both the eukaryotic glutamate transporters and the eukary-
otic neutral-amino-acid carriers mediate thermodynamically
uncoupled ion fluxes. Besides substrate-independent cation
leaks, substrate-dependent Cl2 currents have been reported
(3, 8, 22, 26, 39, 66, 79, 95, 101, 111). The extent of the
substrate-dependent Cl2 flux differs for the various members
of the family but is very high in the glutamate transporters
EAAT4 and EAAT5 from the human brain and retina and
EAAT5A from the salamander retina (3, 22, 26). Thus, these
proteins have a dual function as glutamate transporters and
glutamate-gated chloride channels.
Diversity and Phylogeny
Sixty protein sequences from the Eucarya, Bacteria, and Ar-
chaea, belonging to the glutamate transporter family, were
found in the protein and translated nucleotide databases by
using the BLAST facility (1) (Table 2). The sequences vary in
length from 396 to 581 residues, with the bacterial ones being
significantly shorter (396 to 491 residues) than the eukaryotic
ones (479 to 581 residues). Several organisms contain multiple
paralogues of the family. The bacteria E. coli and B. subtilis
have four paralogues each, whereas in eukaryotes (Homo sa-
piens) up to seven have been found so far. A multiple-sequence
alignment was made with the CLUSTALX program (84). A
stretch of about 150 residues in the C-terminal part of the
sequences is better conserved than the N-terminal part (Fig.
1). This C-terminal part of the alignment, which is unambigu-
ous and contains very few gaps, was used to construct the
phylogenetic tree shown in Fig. 2.
The tree includes a subset of 35 members of the family that
do not contain pairs of sequences with more than 70% iden-
tical residues. Since more similar pairs cluster closely together
in the tree, they are less informative. Several distinct subfam-
ilies can be recognized in the phylogenetic tree of the gluta-
mate transporter family. All eukaryotic members cluster in one
branch of the tree. They have at least 31% identical residues
over the full length. The neutral amino acid transporters and
the glutamate transporters clearly form separate groups within
the eukaryotic branch, supporting the notion that substrate
specificity correlates with phylogenetic classification (64).
However, the eukaryotic and bacterial glutamate transporters
that have similar substrate specificity do not cluster in the tree
but belong to separate subfamilies. Likewise, the eukaryotic
neutral-amino-acid transporters and the bacterial serine trans-
porters are found in different branches of the tree. The analysis
suggests that phylogenetic clustering of members of the family
is determined hierarchically, first by the evolutionary position
of the host organism and second by the substrate specificity
(72).
The bacterial glutamate transporters are found in the same
major branch as the bacterial C4-dicarboxylate transporters,
but within this branch they form separate clusters. The bacte-
rial glutamate transporters have more than 44% identical res-
idues, whereas the C4-dicarboxylate transporters have at least
40% identical residues. The percentage of identical residues
between the members of the GltP and DctA subfamilies varies
from 27 to 42%. In both groups, a protein from B. subtilis that
has not been functionally characterized is present (YhfG and
YdbH, respectively). It is likely that these proteins have the
same substrate specificity as the other members of the subfam-
ilies to which they belong. The two bacterial subfamilies are
more closely related to each other than to the eukaryotic sub-
family. The bacterial and eukaryotic members have 18 to 28%
identical residues.
TABLE 1. Substrate specificity of the members of the glutamate transporter family
Subfamily Kingdoma Substratesb Mode of energy coupling
C4-dicarboxylate transporters B Succinate, fumarate, malate (orotate, aspartate) Unknown
Glutamate/aspartate transporters B, E Glutamate, aspartate, glutamate analogues H1 symport; H1/Na1 symport; H1/Na1
symport-K1 antiport
Neutral-amino-acid transporters B, E Alanine, serine, cysteine, threonine (asparagine,
glutamine)
Exchange; Na1 symport
a B, Bacteria; E, Eucarya.
b High-affinity substrates are shown; substrates in parentheses are not accepted by all members of the subfamilies.
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The serine transporter YgjU of E. coli is only distantly re-
lated to the other characterized members of the family (with at
most 20% identical residues). It is likely that the related pro-
tein YgjU of Haemophilus influenzae (56% identity) is also a
serine transporter. The bacterial serine transporters are found
in a cluster of proteins that branches off from a point near the
center of the tree, indicating that they have diverged from the
other sequences early in evolution (64). The cluster contains a
TABLE 2. Members of the glutamate transporter familya
Name Organism Kingdomb Description No. of residues Accession no.
ASCT2 Ocu Oryctolagus cuniculus E Neutral-amino-acid transporter 541 O19105
ASCT2 Hs Homo sapiens E Neutral-amino-acid transporter 541 O15758
ASCT2 Mmu Mus musculus E Neutral-amino-acid transporter 553 P51912
ASCT1 Hs Homo sapiens E Neutral-amino-acid transporter 532 P43007
ASCT1 Mmu Mus musculus E Neutral-amino-acid transporter 532 O35874
EAAT1 Tni Trichoplusia ni E Glu/Asp transporter 479 AF003006
EAAT3 Mmu Mus musculus E Glu/Asp transporter 523 P51906
EAAT3 Rno Rattus norvegicus E Glu/Asp transporter 523 P51907
EAAT3 Bta Bos taurus E Glu/Asp transporter 524 O95135
EAAT3 Ocuc Oryctolagus cuniculus E Glu/Asp transporter 524 P31597
EAAT3 Hs Homo sapiens E Glu/Asp transporter 524 P43005
EAAT1 Hs Homo sapiens E Glu/Asp transporter 542 P43003
EAAT1 Bta Bos taurus E Glu/Asp transporter 542 P46411
EAAT1 Rnoc Rattus norvegicus E Glu/Asp transporter 543 P24942
EAAT1 Mmu Mus musculus E Glu/Asp transporter 543 737473
EAAT1 Ati Ambystoma tigrinum E Glu/Asp transporter 543 AF018256
EAAT4 Mmu Mus musculus E Glu/Asp transporter 561 O35544
EAAT4 Rno Rattus norvegicus E Glu/Asp transporter 561 O35921
EAAT4 Hs Homo sapiens E Glu/Asp transporter 564 P48664
EAAT5 Hs Homo sapiens E Glu/Asp transporter 560 O00341
GLT5A Ati Ambystoma tigrinum E Glu/Asp transporter 564 AF018259
GLT5B Ati Ambystoma tigrinum E Glu/Asp transporter 544 AF018260
EAAT2 Hs Homo sapiens E Glu/Asp transporter 572 P43004
EAAT2 Mmu Mus musculus E Glu/Asp transporter 572 P43006
EAAT2 Rnoc Rattus norvegicus E Glu/Asp transporter 573 P31596
GLT2A Ati Ambystoma tigrinum E Glu/Asp transporter 579 AF018257
GLT2B Ati Ambystoma tigrinum E Glu/Asp transporter 581 AF018258
EAAT Cel Caenorhabditis elegans E Putative Glu/Asp transporter 503 O10901
EAAT Ovo Onchocerca volvulus E Putative Glu/Asp transporter 492 O25605
EAT2 Cel Caenorhabditis elegans E Putative Glu/Asp transporter 532 O21353
EAT3 Cel Caenorhabditis elegans E Putative Glu/Asp transporter 575 O21751
GLT Cel Caenorhabditis elegans E Putative Glu/Asp transporter 491 Z99277
EAT4 Cel Caenorhabditis elegans E Putative Glu/Asp transporter 502 O22682
GltT Bca Bacillus caldotenax B Glu/Asp transporter 421 P24944
GltT Bst Bacillus stearothermophilus B Glu/Asp transporter 421 P24943
YhfG Bsu Bacillus subtilis B Putative Glu/Asp transporter 429 Y14083
GltP Ec Escherichia coli B Glu/Asp transporter 437 P21345
GltP Bsu Bacillus subtilis B Glu/Asp transporter 414 P39817
DctA Ec Escherichia coli B C4-dicarboxylate transporter 428 P37312
DctA Sty Salmonella typhimurium B C4-dicarboxylate transporter 428 P50334
DctA RleN Rhizobium leguminosarum NGR234 B C4-dicarboxylate transporter 449 S38912
DctA Sme Sinorhizobium meliloti B C4-dicarboxylate transporter 441 P20672
DctA Rle Rhizobium leguminosarum B C4-dicarboxylate transporter 444 Q01857
YdbH Bsu Bacillus subtilis B Putative C4-dicarboxylate transporter 421 AB001488
DctA Mtu Mycobacterium tuberculosis B Putative C4-dicarboxylate transporter 491 Z81451
b1729 Ec Escherichia coli B Unknown 463 AE000268
YB54 Hin Haemophilus influenzae B Unknown 440 P45079
YhcL Bsu Bacillus subtilis B Unknown 463 P54596
GltP Bbu Borrelia burgdorferi B Unknown 463 AE001172
YgjU Ec Escherichia coli B Serine transporter 414 P42602
YgjU Hin Haemophilus influenzae B Putative serine transporter 414 P45246
GltP Aae Aquifex aeolicus B Unknown 398 AE000735
GltP Ser Saccharopolyspora erythraea B Unknown 449 S71005
GltP Cps Chlamydia psittaci B Unknown 406 AF017105
GltP2 Ctr Chlamydia trachomatis B Unknown 415 AE001296
GltP Tpa Treponema pallidum B Unknown 396 AE001231
GltP2 Tpa Treponema pallidum B Unknown 407 AE001262
GltP2 Bbu Borrelia burgdorferi B Unknown 400 AE001145
GltP Ctr Chlamydia trachomatis B Unknown 412 AE001313
GltP Pho Pyrococcus horikoshii A Unknown 425 AB009510
a The BLAST search was performed at the BLAST Website (8a) using the Advance BLAST 2.0 mode. Only sequences from the databases that do not have obvious
sequencing errors are shown; (splicing) variants of the same protein are not shown.
b A, Archaea; B, Bacteria; E, Eucarya.
c Rat EAAT1 and EAAT2 and rabbit EAAT3 are also named GLAST, GLT-1, and EAAC1, respectively. E. coli YgjU is also named SstT.
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FIG. 1. Multiple-sequence alignment of a stretch of approximately 150 residues near the C terminus of the transporters. The alignment was made with the program
CLUSTALX (84). A representative set of 26 members of the glutamate transporter family is shown. Bold numbers refer to the positions in the multiple-sequence
alignment and correspond to the numbers in Fig. 4. Other numbers refer to the residue numbers of the individual sequences. Bars below and above the sequences
indicate the positions of the conserved motifs (motifs A to D, highlighted) and the positions of the transmembrane segments (as published by Grunewald et al. [32]),
respectively. Abbreviated transporter names are taken from Table 2.
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large number of uncharacterized proteins that are only dis-
tantly related to the characterized members of the glutamate
transporter family. The uncharacterized proteins are found not
only in organisms like the chlamydiae (107), which are not
closely related to the organisms in the clusters with character-
ized proteins, but also in organisms like E. coli and B. subtilis,
which have well-characterized members. Therefore, it is likely
that at least some of the uncharacterized members of the
family are proteins with different substrate specificity from the
transporters that have been characterized so far. Among the
uncharacterized members, several subfamilies can be distin-
guished that are likely to consist of proteins with similar, cur-
rently unknown substrate specificity. Hence, b1729 of E. coli,
YB54 of H. influenzae, GltP of Borrelia burgdorferi, and YhcL
of B. subtilis probably are orthologues with the same function.
The same applies to GltP2 of Chlamydia trachomatis and GltP
of Chlamydia psittaci. Two other proteins, GltP2 of Treponema
pallidum and GltP2 of B. burgdorferi, are not included in the
phylogenetic tree (Fig. 2) because they have diverged so far
that it is difficult to unambiguously align them (they have at
most 19 and 17% of residues identical to those of other mem-
bers of the family, respectively). Nevertheless, they are likely to
belong to the family because of the (partial) presence of con-
served motifs and characteristic features of the hydropathy
profiles (see below).
Finally, two sequences occupy separate positions in the tree.
The glutamate transporter homologue GltP Aae from the hy-
perthermophilic bacterium Aquifex aeolicus is more closely re-
lated to the eukaryotic transporters (32 to 39% identical resi-
dues) than to the bacterial members (22 to 32% identical
residues). The separate position of GltP of A. aeolicus in the
tree reflects the unique evolutionary position of this organism
(16). The only archaeal sequence in the tree (GltP Pho) is
equally closely related to the bacterial and eukaryotic se-
quences (approximately 30% of identical residues) and
branches from a point near the center of the tree, reflecting the
distinct phylogenetic position of the archaea (108).
STRUCTURAL ANALYSIS
Hydropathy Profile Analysis
Although the amino acid sequences of the members of the
glutamate transporter family have diverged considerably, their
hydropathy profiles are remarkably similar (40, 53, 77) (Fig. 3).
It is a general property of families of integral membrane pro-
teins that the hydropathy profiles of the members are better
FIG. 3. Alignment of the average hydropathy profiles of the subfamily of bacterial glutamate transporters (thin line) and the subfamily consisting of b1729 of E.
coli, YB54 of H. influenzae, GltP of B. burgdorferi, and YhcL of B. subtilis (thick line) (A) and the subfamilies of bacterial and eukaryotic glutamate transporters (thin
and thick lines, respectively) (B). The profiles were aligned as specified by Lolkema and Slotboom (53) with a window of 19 amino acids. Vertical and horizontal bars
above the profiles indicate the positions of gaps in the sequences and the positions of the transmembrane segments (32), respectively. The profiles are almost
superimposable even though the sequences have considerably diverged. The bacterial glutamate transporters and the subfamily containing YB54 of H. influenzae have
18 to 24% identical residues (A), whereas the subfamilies of bacterial and eukaryotic glutamate transporters have 22 to 29% identical residues (B). The subfamily
containing YB54 of H. influenzae has an extra hydrophobic segment at the N terminus.
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conserved than the primary structures. The conservation of
hydropathy profiles is a reflection of the conservation of the
global structure of the members of a family (53, 54). Quanti-
tative comparison of the hydropathy profiles of different fam-
ilies of secondary transporters has recently been used to group
the transporters into four major structural classes. It was
shown that the hydropathy profile of the glutamate transporter
family is likely to reflect a global structure that is unique
among secondary transporters (53).
The average hydropathy profile derived from the multiple
sequence alignment of a subset of 35 members of the family
(Fig. 4A) emphasizes the conserved characteristics of the pro-
files, which include six alternating hydrophobic and hydrophilic
regions in the N-terminal half and a large hydrophobic region
in the C-terminal half. The subset of 35 members does not
contain any pairs of sequences with more than 70% identical
residues, so that the average profile is not biased toward the
profile of a particular subfamily. The eukaryotic and prokary-
otic members differ predominantly in the length of their hy-
drophilic regions. Three hydrophilic stretches are considerably
longer in the eukaryotic proteins: the N-terminal and C-termi-
nal extensions and the region between the third and fourth
hydrophobic peaks, which is glycosylated in the eukaryotic
members (13). As is commonly observed for families of inte-
gral membrane proteins, the gaps in the multiple-sequence
alignment are found almost exclusively in the hydrophilic
stretches (Fig. 4A).
Membrane Topology
The six hydrophobic segments in the N-terminal part of the
glutamate transporters were predicted to be transmembrane
helices in several reports (38, 67, 81, 88). Experimentally, the
membrane topology of rat EAAT1 (GLAST) was determined
by monitoring the glycosylation state of C-terminally truncated
transporters fused to a reporter peptide with glycosylation sites
(103) and the topology of rat EAAT2 (GLT-1) was assessed by
labeling of single-cysteine mutants (32). Both studies con-
firmed the presence of six membrane-spanning segments in the
N-terminal half of the transporters. Also, the results of trypsin
digestion experiments on rat EAAT2 in membrane vesicles are
consistent with the presence of six N-terminal membrane he-
lices. These studies showed that the N terminus of the protein
is located at the cytoplasmic side of the membrane whereas the
large hydrophilic region between the third and fourth hydro-
phobic segments is extracellular (33), which is in agreement
with the observed glycosylation of this loop in the eukaryotic
transporters (13).
FIG. 4. Average profiles of hydropathy (A) and hydrophobic moment (B) of the glutamate transporter family. The set of 35 members (Fig. 2) which does not contain
pairs of sequences with more than 70% identical residues was used. Vertical and horizontal bars above the profiles indicate the positions of gaps in the sequences and
the positions of the transmembrane segments (32), respectively. Position numbers refer to positions in the multiple-sequence alignment and correspond to the bold
numbers in Fig. 1. In panel A, a window of 19 residues was used and the arrows point to the positions of the conserved motifs A to D. In panel B, a window of 21 residues
and a period of 3.6 residues, appropriate for a-helical structures, was used and the arrows point to the five conserved putative amphipatic helices (AH1 to AH5 from
left to right).
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The C-terminal half of the proteins does not contain clear
alternating regions of high and low hydrophobicity. Therefore,
it is difficult to predict the position of transmembrane segments
from the hydropathy profile. This has led to the proposal of
several different models for the membrane topology of the
proteins (35, 38, 67, 81, 88). The topologies of the C-terminal
halves of rat EAAT1 and EAAT2, B. stearothermophilus GltT,
and a small part of human EAAT1 were experimentally as-
sessed (32, 74, 77, 103). The four studies gave conflicting re-
sults. In the bacterial transporter, four putative membrane-
spanning helices were found (helices 7 to 10) when alkaline
phosphatase was used as the reporter protein. Accessibility
scanning of single-cysteine mutants of rat EAAT2 revealed two
membrane-spanning helices at the same positions as helices 7
and 10 in the bacterial system. In addition, two short mem-
brane-spanning segments of approximately 10 residues each
were found in the region where bacterial helices 8 and 9 were
proposed (Fig. 5). The two short membrane-spanning seg-
ments may form a reentrant loop or a loop-pore structure
reminiscent of those found in ion channels (19, 55, 56). In the
third study, on rat EAAT1, four membrane-spanning b-strands
were proposed at significantly different positions from the
membrane-spanning segments in the other studies. This model
is not consistent with results of trypsin digestion studies on
membrane vesicles containing rat EAAT2 (GLT-1). These ex-
periments showed that the C terminus of the protein and the
hydrophilic region following transmembrane segment 6 are
located at the cytoplasmic side of the membrane (32, 33). The
other two models are both consistent with these results and
display several similar features, most importantly the presence
of two membrane-spanning segments (numbered 7 and 10)
that may form an important part of the substrate recognition
site and translocation pore (see below). The only difference
between the models is the position and length of membrane-
spanning segments 8 and 9. At present, we tentatively favor the
model with two helices and the loop-pore structure for the
C-terminal part of the proteins, since it is based on the study of
full-length and active carriers. Truncated transporters fused to
reporter proteins may fold in a nonnative conformation (89).
This may be especially the case when the protein does not
consist of a conventional bundle of membrane-spanning a-he-
lices.
A small part of the topology of human EAAT1 was also
determined by accessibility scanning of single-cysteine mutants
(74). The examined region includes the putative membrane-
spanning segment 7 and its flanking sequences. It was sug-
gested that rather than being a membrane-spanning helix, this
region forms another reentrant loop with both ends positioned
at the extracellular side of the membrane. This implies that an
extra membrane-spanning segment must be present between
the cytoplasmic end of helix 6 and the extracellular beginning
of this putative reentrant loop. At present it is not possible to
explain the discrepancies between the models for the mem-
brane topology of rat EAAT2 and human EAAT1, since both
studies are based on a similar experimental approach, the
analysis of active single-cysteine versions of the transporters.
Again we tentatively favor the model proposed by Grunewald
et al. (32). Only their model is consistent with the trypsin
FIG. 5. Model for the membrane topology of the C-terminal part of the glutamate transporters comprising membrane-spanning segments 7 to 10 (based on the
model of Grunewald et al. [32]). The sequence of rat EAAT2 (GLT-1) is shown. Membrane segments 7 and 10 are likely to be helices and were also proposed in the
model of Slotboom et al. (77). Membrane segments 8 and 9 form a reentrant loop or loop-pore structure according to Grunewald et al. (32). Conserved motifs B and
C and the conserved hydrophilic face of helix 10 (motif D) are shaded. Tyrosine 403, which is involved in potassium binding and is accessible from either side of the
membrane depending on the presence of substrates, is located in the middle of helix 7.
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digestion studies, discussed above, that demonstrated the in-
tracellular location of the region between putative helices 6
and 7. Clearly, the topology of the C-terminal part of the
transporters has to be further examined, not only because of
the conflicts between the different models but also since loop-
pore structures which are found in several ion channels (19, 55,
56) have not been found in secondary transporters before. A
model for the membrane topology of the C-terminal half of the
transporters is shown in Fig. 5. The positions of the membrane-
spanning segments are indicated in Fig. 1 and 4a.
Periodicity Properties
The members of the glutamate transporter family were ex-
amined for patterns of residue hydrophobicity and residue
conservation (or substitution) in their amino acid sequences
(21, 77). Figure 4B shows the average periodicity profile of
amino acid hydrophobicity of the family (amphipathy profile)
with a period of 3.6 residues, appropriate for a-helical struc-
tures. The glutamate transporter family contains five regions
with conserved hydrophobic moments that could form amphi-
pathic a-helices (AH1 to AH5, Fig. 4B). AH1 to AH4 are
found in loop regions connecting the putative transmembrane
helices and may therefore form membrane surface helices with
the axis parallel to the plane of the membrane and the hydro-
philic residues exposed to the aqueous phase. AH2 and AH4
are found exclusively in the eukaryotic transporters. The hy-
drophobic moment of AH5 is conserved in all members of the
family and has a particularly large value of 0.45 to 0.6/residue
in the glutamate and C4-dicarboxylate transporters, which is
larger than that of the peptide melittin, a considerably amphi-
patic peptide with a known a-helical structure (20). The hy-
drophobic moment is somewhat smaller in the mammalian
neutral-amino-acid transporters and the bacterial serine trans-
porters (0.3 to 0.4/residue). The putative amphipathic a-helix
AH5 coincides with transmembrane segment 10 and thus pro-
vides a hydrophilic path through the membrane. It was sug-
gested that this amphipathic membrane-spanning helix could
provide part of the translocation pore (77). This suggestion
recently gained experimental support in studies on chimeric
transporters (see below).
Within transmembrane helices, the pattern of residue con-
servation (or substitution) can be used to discriminate between
buried and lipid-exposed residues (18). The amphipathic mem-
brane-spanning helix 10 has an exceptionally large substitution
moment with a-helical periodicity (0.09/residue) (77). The hy-
drophobic face of the helix is less well conserved than the
hydrophilic face, and it is likely that the membrane-spanning
helix has a lipid-exposed hydrophobic face and a protein-bur-
ied, well-conserved hydrophilic face. The other putative mem-
brane-spanning segments have considerably smaller substitu-
tion moments, but the moments of helices 1 and 3 (0.06 and
0.05/residue, respectively) may be significant.
Sequence Motifs
The glutamate transporter family does not contain residues
that are conserved in all members. This is due to the inclusion
of several distantly related sequences in the family that have
emerged from recent genome-sequencing projects. For the
same reason, most of the previously described “signature se-
quences” for the glutamate transporter family are not found in
all the members listed in Table 2 (70). Only one sequence
motif is conserved in all members of the family. This is a
serine- and threonine-rich stretch in the hydrophilic region of
the proteins following membrane-spanning helix 6 (motif A,
Table 3 and Fig. 1 and 4A). It is located intracellularly in the
topology model proposed by Grunewald et al. (32). Serine
clusters were found in the ligand binding sites of the metabo-
tropic glutamate receptors and in G-protein-coupled acetyl-
choline and biogenic amine receptors (62, 105). It was sug-
gested that the stretch in the glutamate transporters may have
a similar function (40), though there is as yet no conclusive
experimental indication of such a function (59).
A second motif that was suggested to be involved in sub-
strate binding (67) is AX(I/V/L)F(L/I)AQ (motif C, Table 3
and Fig. 1), which is located in the putative membrane-span-
ning helix 7 (32, 77, 109). The motif is conserved in the gluta-
mate, neutral-amino-acid, and C4-dicarboxylate carriers but
not in most of the uncharacterized bacterial proteins. It may
therefore be involved in binding of a carboxylate group of the
substrate, which is the only functional group common to all
substrates of the carriers that contain the motif. The motif is
part of a stretch of 76 residues that is involved in the binding
of dihydrokainate, a glutamate analogue that competitively
inhibits glutamate transport (95) (see below). This observation
is consistent with the hypothesis that the motif is involved in
substrate binding.
The motif PXGX(T/S)XN(M/L)DGXX(L/I)(F/Y), located
at the cytoplasmic interface of membrane helix 7, is present in
all of the functionally characterized and most of the putative
transporters (motif B, Table 3 and Fig. 1). This motif has been
subjected to extensive mutagenesis studies and is involved in
cation binding (see below). The stretch that forms the amphi-
pathic membrane helix 10 (motif D) is conserved in most
members of the family, but its exact amino acid composition
varies along with the substrate specificity of the transporters
(Table 3). The substrate-specific differences in this stretch are
consistent with the hypothesis that the amphipathic mem-
brane-spanning helix 10 may be part of the translocation pore
(59, 77). Finally, the human glutamate transporter EAAT5
contains a C-terminal consensus motif for interaction with
TABLE 3. Sequence motifs in the glutamate transporter family
Motif Start positiona Sequenceb End positiona
A 414 (ST)(STARK)S(ST) 417
B 443 PxGx(TS)xN(ML)DGxx(LI)(FY) 457
C 461 Ax(IVL)F(LI)AQ 467
D (eukaryotic glutamate transporters) 531 DWxLDRxRTxxNVxGD 546
D (eukaryotic neutral-amino-acid transporters) 531 DWxVDRxxTxxNVEGD 546
D (bacterial glutamate transporters) 531 DRxxDMARTxxNxxG(NH) 546
D (bacterial C4-dicarboxylate transporters) 531 DRFMSExRxxxNxxGN 546
D (bacterial serine transporters) 531 GxLQDSxETALNSSTD 546
a Numbers refer to positions in the multiple-sequence alignment of Fig. 1.
b When two or more residues are indicated in parentheses, either of the them is found; x refers to nonconserved residues.
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synaptic proteins that promote ion channel clustering (3).
EAAT5 is one of the glutamate transporters that shows large
substrate-dependent chloride currents (see above), and clus-
tering with components of the signal transduction pathway may
point to the function of the chloride currents.
FUNCTIONAL ANALYSIS
Catalytic Cycle
Extensive characterization of the eukaryotic glutamate car-
riers EAAT1 to EAAT3 has resulted in the model for the
transport cycle that is shown in Fig. 6 (44). The transporters
catalyze the uptake, efflux, and exchange of glutamate. In up-
take and efflux, the complete cycle is followed in the forward
and reverse directions, respectively, whereas during exchange,
steps 1 to 7 (Fig. 6) are followed alternately in the forward and
reverse directions. K1 is required only to reorient the empty
carrier (steps 8 to 10). Exchange is not dependent on potas-
sium ions, since reorientation of the empty carrier is omitted.
The bacterial glutamate transporters also catalyze uptake, ef-
flux and exchange, but none of the transport modes is believed
to require potassium ions (87); the empty carrier reorients
spontaneously.
The binding order of Na1, H1, and glutamate (steps 1 to 3)
is a matter of debate. Kanner and coworkers (42, 68) showed
that exchange catalyzed by rat EAAT2 does not require exter-
nal Na1 at saturating glutamate concentrations whereas it does
at nonsaturating glutamate concentrations. They concluded
that all cotransported sodium ions bind to the transporter prior
to glutamate binding. In contrast, Kanai et al. (39) found that
binding of sodium ions is modulated by glutamate, and in their
model one Na1 ion binds after the binding of glutamate (see
also references 17 and 47). The observations indicate that the
glutamate and Na1 binding sites intimately interact, which is in
agreement with the results of recent mutagenesis studies (69,
114) (see below). The binding order may depend on the con-
ditions used. The catalytic cycle of the neutral-amino-acid
transporters may be similar to that of the exchange mode of
the glutamate transporters. The human neutral-amino-acid
transporter ASCT1 catalyzes electroneutral exchange of amino
acids that is dependent on Na1 but not on K1, just like ex-
change catalyzed by the glutamate transporters (111). One
difference is the Na1 stoichiometry, since only one sodium ion
was found to interact with the neutral-amino-acid transporters
(93, 111).
Substrate Binding Site
Several inhibitors of the glutamate transporters have been
found, some of which have different specificities for different
members of the family (4, 49, 96, 98). Noncompetitive inhibi-
tors include oxidizing agents like ONOO2, which covalently
interact with glutamate transporters and specifically inhibit the
Vmax of transport (90, 91, 99, 100), and Zn
21, which is a partial
inhibitor of the human and salamander glutamate transporters
EAAT1 (80, 97). Arachidonic acid inhibits some glutamate
transporter subtypes but stimulates others (92, 110).
Most of the competitive inhibitors of the glutamate trans-
porters were found to be substrates of the proteins that are
transported with a high affinity (Km , 100 mM), e.g., D-aspar-
tate, cysteate, and threo-b-hydroxyaspartate (Fig. 7) (38, 67,
81). Only a few competitive inhibitors that are not transported
have been identified, such as threo-b-benzyloxyaspartate and
kainate, a specific inhibitor of the EAAT2 subtypes (Fig. 7) (9,
49, 76, 96). The conformations of glutamate and aspartate in
the substrate binding site have been modeled by comparing the
FIG. 6. Schematic representation of the transport cycle of the eukaryotic
glutamate transporters (44). T, transporter; glu2, glutamate; n, the number of
sodium ions that bind after glutamate binding. A description is given in the text.
FIG. 7. Structures of some transported substrates (A, B, D, E, and F) and
competitive inhibitors (G and H) of the glutamate transporters. 4-Methylgluta-
mate (C) is a substrate of some transporters but a competitive inhibitor of others.
(A) Glutamate; (B) b-hydroxyaspartate; (C) 4-methylglutamate; (D) serine-O-
sulfate; (E) cysteate; (F) pyrrodiline-2,4-dicarboxylate; (G) kainate; (H) b-ben-
zyloxyaspartate.
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structures of transported glutamate analogues and competitive
blockers of the transporters (9, 10, 14, 49, 96). It was originally
proposed that glutamate binds to the transporters in a folded
form and aspartate binds in the extended form. In these con-
formations, the functional groups of the transported substrates
(one amino group and two carboxylate groups) can be super-
imposed. However, more recent data from the analysis of con-
formationally constrained glutamate analogues showed that
compounds that mimic the folded conformation as well as
compounds that mimic a stretched conformation of glutamate
bind to glutamate transporters but that only the “stretched”
compounds can be transported (25).
The nature and diastereomeric properties of the substituents
at the b-carbon (C-3 position) of aspartate determine whether
aspartate analogues are transported substrates or competitive
blockers (49, 96). Thus, derivatives of aspartate with small
groups at the b-carbon, such as b-hydroxyaspartate (Fig. 7B)
and the related compounds b-acetoxyaspartate and b-propio-
nyloxyaspartate, are transported by the bovine glutamate
transporters EAAT1 and EAAT2 with high affinity (Km 10 to
100 mM). Derivatives with bulkier groups at the b-carbon, such
as b-benzyloxyaspartate (Fig. 7H), are competitive blockers (Ki
, 20 mM) (49, 76).
The transporters are less tolerant in accepting derivatives of
glutamate as substrates. (2S,4S)-4-Methylglutamate (Fig. 7C)
is not recognized by human EAAT1 and EAAT2, whereas its
stereoisomer (2S,4R)-4-methylglutamate is a substrate for
EAAT1 (Km 5 54 mM) but a competitive blocker of EAAT2
(Ki 5 3.4 mM). Both stereoisomers of 4-hydroxyglutamate are
transported by the human glutamate transporters EAAT1 and
EAAT2, but the affinity for erythro-4-hydroxyglutamate is very
low (Km . 1 mM) (96). Substitutions at the C-3 position are
even less well tolerated. None of the stereoisomers of 3-meth-
ylglutamate is recognized by EAAT1, while only the stereoiso-
mer threo-3-methylglutamate is bound, but not transported, by
EAAT2 (Ki 5 2.3 mM).
In the human glutamate transporter EAAT3, the stoichiom-
etry of proton-substrate symport was found to depend on the
charge of the transported substrate (112). Thus, transport of
compounds which are anionic at physiological pH, like gluta-
mate (pKa 5 4.5) and cysteate (pKa 5 1.5) (Fig. 7E), is asso-
ciated with the symport of one proton. However, transport of
cysteine, a low-affinity substrate for EAAT3 that is neutral at
physiological pH (pKa 5 8.3), is transported without a proton.
Based on these observations, it was suggested that the anionic
substrates are transported in the protonated state, i.e., as glu-
tamic acid or cysteic acid (112). This mechanism of proton
transport is feasible if the pKa of the anionic substrates is
raised sufficiently in the substrate binding site of the trans-
porter. This can be achieved by destabilizing the negative
charge on the substrate in an apolar or negatively charged
surrounding. However, this mechanism may be improbable
since some substrates, like serine-O-sulfate (pKa , 0) (Fig.
7D), are so acidic that protonation is not likely to occur (98).
Alternatively, the observed substrate-dependent proton stoi-
chiometry could be explained if the formation of a hydrogen
bridge between the substrate and a residue in the substrate
binding site were essential (Fig. 8). Then, transport of anionic
substrates requires a proton to bind in the substrate binding
site to form the hydrogen bridge whereas uncharged sub-
strates, like cysteine and glutamic acid, provide the proton for
the hydrogen bridge themselves. This mechanism implies that
the substrate binding site can exist in a protonated state and a
unprotonated state, which can be accounted for by, for in-
stance, the presence of a histidine residue, although other
residues can also be envisaged (Fig. 8). The symported proton
is shared by the substrate and the proton-accepting residue in
the substrate binding site.
Only at low pH are glutamate and cysteate also transported
by the neutral-amino-acid transporters ASCT2 from mice, rab-
bits, and humans (46, 82, 93). The pH dependence of transport
of the anionic compounds is caused by protonation of a residue
on the transporter, possibly a histidine (82). Glutamate may
therefore be transported by ASCT2 in a similar way to that by
the glutamate transporters (93). However, unlike the gluta-
mate transporters that may have a protonated substrate bind-
ing site at physiological pH, the neutral-amino-acid transport-
ers are optimized for transport of neutral compounds and are
normally not protonated. Nevertheless, since glutamate is a
substrate for both the glutamate transporters and the neutral-
amino-acid transporters, the substrate binding pockets of the
transporters may have a similar spatial structure (93). A fur-
ther indication for this suggestion is the observation that cys-
teine, a common substrate for the neutral-amino-acid trans-
porters, is transported with low affinity by the human
glutamate transporter EAAT3 (Km 5 190 mM) (113).
Differences in inhibitor specificity as well as differences in
Cl2 permeability between the human glutamate transporters
EAAT1 and EAAT2 have been used to identify domains that
may be part of the substrate binding site and translocation
pore. Chimeras were constructed, and it was shown that a
stretch of 76 residues comprising the conserved motifs B and C
and membrane-spanning segment 7 (Fig. 5) is involved in the
binding of dihydrokainate, a glutamate analogue and nontrans-
ported competitive inhibitor of EAAT2 (95). The region com-
prising membrane-spanning segment 10, including motif D, is
also involved in inhibitor recognition and accounts for differ-
ences in the chloride permeability as well (59). Hence, mem-
brane-spanning segments 7 and 10 may form an important part
of the substrate recognition site and translocation pore. Kanai
et al. constructed chimeras between mouse EAAT2 and
EAAT3 and showed that a region of 38 residues comprising
conserved motif A (Fig. 5) is also involved in the recognition of
dihydrokainate (41). However, dihydrokainate binds to an ex-
ternal site of the transporters (102), and in the topology model
proposed by Grunewald et al. (32) this region is located intra-
cellularly (Fig. 5). Therefore, it is unlikely that the region is
directly involved in dihydrokainate binding, unless the topol-
ogy model of the region is not correct (59).
FIG. 8. Model for hydrogen bridge formation between a residue in the sub-
strate binding site of the glutamate transporters (histidine is used as an example)
and the substrates glutamate (A) and cysteine (B). Hydrogen bridge formation
can explain the observed substrate-dependent proton stoichiometry (112) (see
the text).
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Cation Binding Sites
Differences in the amino acid sequences of members of the
glutamate transporter family have been used as a guide to find
residues of the substrate binding site or translocation pore (12,
97, 115). A list of single and multiple amino acid substitutions
that have been made in members of the glutamate transporters
family is shown in Table 4. Mutations that completely abolish
transport may be useful to delineate functionally or structurally
important regions in the proteins. Thus, it was shown that two
of the conserved hydrophilic residues in helical membrane-
spanning segment 10 (Asp-470 in rat EAAT2 [69] and Arg-479
in rat EAAT1 [12]) are indispensable for transport activity.
This is consistent with the suggestion that the hydrophilic face
of segment 10 is part of the translocation pore (77). The exact
function of residues that are indispensable for transport func-
tion is, however, difficult to assess.
The most informative mutants are those that alter a specific
property of the transporters. Extensive mutagenesis studies of
conserved motif B at the cytoplasmic end of membrane-span-
ning helix 7 (Fig. 5) in rat EAAT2 have shown that two resi-
dues (Y403 and E404) are involved in the binding of potassium
ions (44, 114). Transporters in which these residues are con-
servatively mutated are unable to complete the transport cycle
shown in Fig. 6 because they cannot reorient the empty carrier,
which is due to a defect in K1 binding and/or translocation.
These mutant transporters are, however, able to catalyze ex-
change that is K1 independent. Cysteine modification and
protection studies on the Y403C mutant showed that this res-
idue is alternately accessible from either side of the membrane
depending on the presence of substrates or transport blockers
(109). This is in agreement with the alternating accessibility of
the K1 binding site from both sides of the membrane in the
transport cycle (Fig. 6). Interestingly, E404 in rat EAAT2 is
conserved in all eukaryotic glutamate transporters but not in
the bacterial carriers and the neutral-amino-acid transporters
(Fig. 1). This correlates with the observations that the neutral-
amino-acid transporters are K1-independent obligate ex-
changers and that the bacterial transporters are glutamate
cation symporters. Y403 of rat EAAT2 is not conserved in the
neutral-amino-acid transporters either, but it is conserved in
the bacterial carriers. Mutations of Y403 and E404 in rat
EAAT2 also affect the Na1 and glutamate selectivity of the
transporters, respectively, indicating that the three binding
sites intimately interact (69, 114). The E404D mutant strongly
prefers aspartate over glutamate, whereas the Y403W and
Y403F mutants have an increased affinity for sodium ions but
have lost the strict dependency on Na1 and also accept lithium
and cesium ions. The proximate residues 396 to 400 in rat
EAAT2 that are indispensable for transport were suggested to
be part of the Na1 binding site(s) (109). These residues are
also conserved in the bacterial glutamate transporters that do
not use sodium ions. Furthermore, D304 of B. stearothermophi-
lus GltT (the counterpart of D398 of rat EAAT2) is indispens-
able for function (78). Therefore these residues may be, more
generally, involved in cation binding.
PROSPECTS
As long as a high-resolution structure of (one of) the mem-
bers of the glutamate transporter family is not available, struc-
tural features must be obtained from biochemical and biophys-
ical experiments. Mutagenesis studies and studies on chimeric
transporters have so far proved to be very informative in pro-
viding information on the function of individual residues and
domains, respectively. Mutagenesis is likely to remain useful as
long as mutants with interesting properties can be found. One
way to find interesting residues is to look for second-site re-
vertants of mutant transporters that are inactive. For this, the
bacterial members of the family can be used.
Cysteine-scanning mutagenesis is likely to become a major
source of structural information. This technique has been ex-
tensively used in the study of the lactose transporter LacY
from E. coli (30, 36), and the first results from this technique
are now available for members of the glutamate transporter
family. To fully benefit from the possibilities offered by cys-
teine-scanning mutagenesis, it will be necessary to use purified
and reconstituted transporters. Such a pure system allows the
use of a number of spectroscopic techniques to study both
structural and dynamic properties of the transporters. The rat
EAAT2 and B. stearothermophilus GltT glutamate transporters
have been purified to homogeneity and reconstituted into pro-
teoliposomes (15, 31). The bacterial system is suitable for the
expression and large-scale purification of both wild-type and
mutant transporters.
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